May 7 (SeeNews) - Bulgarian investment firm ImPulse Growth [BUL:IMP] said on Wednesday that its ImVenture III fund is investing 500,000 euro ($567,153) in UK-based biotech startup GlycanAge as part of a $5 million funding round.